Scarica l'app Stockscreener
2.78
9.45%
-0.29
Pre-mercato:
2.89
0.11
+3.96%
Precedente Chiudi:
$3.07
Aprire:
$2.99
Volume 24 ore:
423.23K
Relative Volume:
1.02
Capitalizzazione di mercato:
$38.85M
Reddito:
$12,000
Utile/perdita netta:
$-48.50M
Rapporto P/E:
-0.1629
EPS:
-17.0687
Flusso di cassa netto:
$-19.78M
1 W Prestazione:
-16.01%
1M Prestazione:
-66.18%
6M Prestazione:
-84.86%
1 anno Prestazione:
-88.42%
Intervallo 1D:
$2.7775
$3.02
Intervallo di 1 settimana:
$2.7775
$3.30
Portata 52W:
$2.40
$49.80
Incannex Healthcare Inc Stock (IXHL) Company Profile
Nome
Incannex Healthcare Inc
Settore
Telefono
61 409 840 786
Indirizzo
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
2.78 | 38.85M | 12,000 | -48.50M | -19.78M | -17.07 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Incannex Healthcare Inc Borsa (IXHL) Ultime notizie
Incannex says it holds $75 million in cash with zero debt after financing - MSN
Incannex Healthcare Company Profile & Introduction - Moomoo
IXHL Stock Price, Quote & Chart | INCANNEX HEALTHCARE INC (NASDAQ:IXHL) - ChartMill
IXHL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Incannex reports $75M cash position with no debt after financing By Investing.com - Investing.com South Africa
Incannex reports $75M cash position with no debt after financing - Investing.com Australia
Incannex Highlights $75 Million Cash, No Debt, and Advances IHL-42X and PSX-001 Clinical Programs - Minichart
Incannex approves 1-for-30 reverse stock split to regain Nasdaq compliance - MSN
Incannex Healthcare Inc. (IXHL) implements 1-for-30 reverse split effective February 26 - MSN
Incannex Healthcare Strengthens Cash Position, Highlights Clinical Pipeline - TipRanks
Incannex Highlights $75M Cash, No Debt as It Funds DReAMzz Phase 2 and Advances IHL-42X - TradingView
Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development - The Manila Times
Incannex (Nasdaq: IXHL) highlights $75M cash, no debt and advancing trials - Stock Titan
Market values Incannex at $46M despite $75M in cash - Stock Titan
Incannex regains Nasdaq compliance with minimum bid price By Investing.com - Investing.com South Africa
Incannex Healthcare Regains Nasdaq Compliance and Advances Clinical Pipeline with Strong Cash Position - Minichart
Incannex regains Nasdaq compliance with minimum bid price - Investing.com
Incannex regains compliance with Nasdaq minimum bid price requirement - marketscreener.com
Incannex Regains Nasdaq Compliance, Strengthening Pipeline Progress - TipRanks
Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Incannex Healthcare (NASDAQ: IXHL) restores Nasdaq bid price compliance, highlights $75M cash - Stock Titan
Biotech Incannex clears Nasdaq listing hurdle, holds $75M cash and no debt - Stock Titan
Incannex outlines dose-optimization study for sleep apnea treatment - MSN
Incannex Stock Slides As $10 Million Capital Raise Funds Next Study For Sleep Apnea Treatment - Yahoo Finance UK
Incannex Healthcare Announces $10 Million Direct Offering - The Globe and Mail
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Sahm
Why did IXHL stock slump 20% in pre-market today? - MSN
Incannex plans dose-optimization study for sleep apnea drug By Investing.com - Investing.com South Africa
IHL.AX Incannex Healthcare (ASX) A$0.041 intraday 13 Mar 2026: Phase 2 news drives volume - Meyka
Incannex plans dose-optimization study for sleep apnea drug - Investing.com Australia
Incannex Healthcare (NASDAQ: IXHL) sells 1.997M units for ~$9M - Stock Titan
Will Incannex Healthcare Inc benefit from AI trends2026 Retail Activity & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Incannex Updates Clinical Pathway for Sleep Apnea Drug Candidate IHL-42X - Sleep Review
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Incannex Healthcare stock drops 20% after $10 mn private placement | Tap to know more | Inshorts - Inshorts
Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes - Bitget
Why Did IXHL Stock Slump 20% In Pre-Market Today? - Asianet Newsable
Incannex prices 2M shares at $5.00 in registered direct offering - TipRanks
Incannex Healthcare prices $10M registered direct offering - MSN
Incannex announces enhanced development strategy for IHL-42X - TipRanks
Why Did IXHL Stock Slump 35% Today? - Stocktwits
Incannex Healthcare Inc Shares Drop 20% After $10 Million Placement Announcement - Intellectia AI
Incannex Highlights Enhanced Phase 2 Study and Updates - TipRanks
Incannex Healthcare Inc. (NASDAQ: IXHL) officially announced that the company has completed the pricing of a registered direct offering with a total size of 10 million dollars. - Bitget
Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
Incannex Healthcare Inc Azioni (IXHL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):